China SXT Pharmaceuticals-ASXTC
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 10 institutions reported holding China SXT Pharmaceuticals-A (SXTC) in their 13F filings, up 6 from Q2 2025. 7 opened new positions and 1 sold out. The largest holders were Invesco Ltd. ($141K), Geode Capital Management, LLC ($85K) and Citadel Advisors ($78K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- China SXT Pharmaceuticals-A
- CUSIP
- G2161P157
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $440K |
| Exits | 1 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 296,617 shares bought and 62,547 shares sold, net +234,070 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Invesco Ltd. | 0.00% | New | 89,660 | $141K |
| Geode Capital Management, LLC | 0.00% | New | 53,671 | $85K |
| Citadel Advisors | 0.00% | New | 48,759 | $78K |
| Renaissance Technologies | 0.00% | New | 44,500 | $70K |
| Virtu Financial LLC | 0.00% | Add +107.5% | 28,983 | $46K |
| HRT Financial LP | 0.00% | New | 26,749 | $42K |
| Two Sigma Securities, LLC | 0.00% | New | 15,449 | $24K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1806.0% | 2,878 | $5K |
| UBS Group AG | 0.00% | Reduce -99.8% | 100 | $157 |
| State of Wyoming | 0.00% | New | 89 | $142 |
"% of holder's portfolio" is SXTC's weight in each manager's 13F, not the share of China SXT Pharmaceuticals-A the manager owns.